Johnson & Johnson (JNJ) announced its plans to invest over $55 billion over the next four years in the U.S. to strengthen its ...

J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.

Johnson & Johnson said on Friday it plans to invest more than $55 billion over the next four years to build manufacturing ...

The Moving Average Convergence Divergence (MACD) at -2.59 indicator supports a bearish sentiment, although the Relative Strength Index (RSI) at 26.32 suggests J&J stock is deeply oversold.

Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies. Please watch the video at Investors.com - How To Buy ...

Genmab A/S said that Johnson & Johnson has decided not to exercise its option to obtain a worldwide license for the ...

After a strong gain in the past week, it's worth seeing if longer term returns have been driven by improving fundamentals. See our latest analysis for J&J Snack Foods . In his ess ...

Pharmaceutical giant Johnson&Johnson became the latest company to announce a massive investment in the U.S. to appease President Donald Trump.

Morgan Stanley says intra-day pressure on Genmab (GMAB) of greater than 5% after Genmab announced that partner Johnson & Johnson (JNJ) has ...

Investing.com -- Genmab (CSE: GMAB) (NASDAQ: GMAB) announced on Monday, March 10, that Johnson & Johnson (NYSE: JNJ) has ...

The decision comes after Genmab provided J&J with data from a clinical proof-of-concept study, which included a head-to-head comparison with DARZALEX FASPRO® (daratumumab and hyaluronidase fihj) in ...

Detailed price information for J J Snack Foods (JJSF-Q) from The Globe and Mail including charting and trades.